Increasing prevalence of coeliac disease in Denmark: a linkage study combining national registries

Stine Dydensborg1, Peter Toftedal, Matteo Biaggi

  • 1Hans Christian Andersen Children's Hospital, Odense University Hospital, Odense C, Denmark.

Insights

The prevalence of diagnosed coeliac disease (CD) in Danish children and adolescents has significantly increased over a 15-year period. This trend highlights a growing need for awareness and early diagnosis of CD in pediatric populations.

Area of Science:

  • Pediatric Gastroenterology
  • Epidemiology
  • Public Health

Background:

  • Coeliac disease (CD) is a significant autoimmune disorder affecting children and adolescents.
  • Understanding the epidemiological trends of CD is crucial for public health planning and resource allocation.

Purpose of the Study:

  • To determine the prevalence and incidence of diagnosed coeliac disease (CD) in Danish children and adolescents.
  • To analyze temporal trends in CD diagnosis and associated factors over a 15-year period.

Main Methods:

  • Utilized data from the Danish National Patient Registry (DNPR) for CD diagnoses.
  • Validated diagnoses using small-bowel biopsy data from the National Registry of Pathology (NRP) and hospital records.
  • Analyzed data spanning from 1996 to 2010.

Main Results:

  • Registered CD prevalence in children increased from 43.2 to 83.6 per 100,000.
  • Registered CD incidence rose from 2.8 to 10.0 per 100,000.
  • Biopsy-verified CD incidence increased significantly, and the mean age at diagnosis rose to 8.1 years.

Conclusions:

  • The prevalence of diagnosed coeliac disease in Danish children and adolescents has notably increased over the past 15 years.
  • This upward trend indicates a growing burden of coeliac disease in the pediatric population.
Abstract

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...